$1.57 Billion is the total value of Centerbridge Partners's 71 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 41.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GTXAP | GARRETT MOTION INCpfd conv ser a | $547,534,000 | -1.3% | 66,207,182 | 0.0% | 34.95% | +10.4% | |
| IWM | Buy | ISHARES TRput | $343,212,000 | +48.4% | 1,672,000 | +60.8% | 21.90% | +66.0% |
| FUN | Buy | CEDAR FAIR L Pdepositry unit | $162,509,000 | +46.0% | 2,965,496 | +33.4% | 10.37% | +63.4% |
| RADI | RADIUS GLOBAL INFRASTRCTRE I | $156,009,000 | -11.3% | 10,925,000 | 0.0% | 9.96% | -0.8% | |
| GNK | GENCO SHIPPING & TRADING LTD | $107,815,000 | +47.6% | 4,564,583 | 0.0% | 6.88% | +65.2% | |
| INDT | Buy | INDUS REALTY TRUST INC | $99,200,000 | +25.0% | 1,357,233 | +38.7% | 6.33% | +39.9% |
| GOCO | GOHEALTH INC | $48,006,000 | -68.9% | 40,682,961 | 0.0% | 3.06% | -65.2% | |
| GTX | GARRETT MOTION INC | $24,374,000 | -10.5% | 3,390,000 | 0.0% | 1.56% | +0.2% | |
| VTIQ | VECTOIQ ACQUISITION CORP II | $19,168,000 | +0.9% | 1,950,000 | 0.0% | 1.22% | +12.8% | |
| CYH | Sell | COMMUNITY HEALTH SYS INC NEW | $17,638,000 | -27.8% | 1,485,900 | -16.6% | 1.13% | -19.2% |
| GDS | GDS HLDGS LTDsponsored ads | $13,345,000 | -16.8% | 340,009 | 0.0% | 0.85% | -6.9% | |
| FAF | New | FIRST AMERN FINL CORP | $12,964,000 | – | 200,000 | +100.0% | 0.83% | – |
| FUN | CEDAR FAIR L Pcall | $12,483,000 | -81.1% | 227,800 | 0.0% | 0.80% | -78.9% | |
| AGCB | ALTIMETER GROWTH CORP 2 | $1,473,000 | -0.4% | 150,000 | 0.0% | 0.09% | +11.9% | |
| New | ALPHA TAU MEDICAL LTD*w exp 03/07/202 | $305,000 | – | 50,000 | +100.0% | 0.02% | – | |
| VTIQW | VECTOIQ ACQUISITION CORP II*w exp 01/07/202 | $175,000 | -46.5% | 389,999 | 0.0% | 0.01% | -42.1% | |
| CFVIW | CF ACQUISITION CORP VI*w exp 02/18/202 | $129,000 | +31.6% | 37,500 | 0.0% | 0.01% | +33.3% | |
| LCAHW | LANDCADIA HOLDINGS IV INC*w exp 03/29/202 | $63,000 | -50.0% | 125,000 | 0.0% | 0.00% | -42.9% | |
| BGSXWS | BUILD ACQUISITION CORP*w exp 03/15/202 | $41,000 | -60.6% | 149,999 | 0.0% | 0.00% | -50.0% | |
| CFIVW | CF ACQUISITION CORP IV*w exp 12/31/202 | $40,000 | -45.9% | 99,999 | 0.0% | 0.00% | -25.0% | |
| PRPCWS | CC NEUBERGER PRINCIPAL HOLDN*w exp 99/99/999 | $50,000 | -42.5% | 80,000 | 0.0% | 0.00% | -40.0% | |
| AFAQW | AF ACQUISITION CORP*w exp 03/23/202 | $51,000 | -56.8% | 200,000 | 0.0% | 0.00% | -57.1% | |
| PAQCW | PROVIDENT ACQUISITION CORP*w exp 01/08/202 | $32,000 | -20.0% | 74,999 | 0.0% | 0.00% | 0.0% | |
| DUNEW | DUNE ACQUISITION CORP*w exp 10/29/202 | $33,000 | -54.8% | 149,999 | 0.0% | 0.00% | -50.0% | |
| RXRAW | RXR ACQUISITION CORP*w exp 03/08/202 | $9,000 | -35.7% | 19,999 | 0.0% | 0.00% | 0.0% | |
| FACAWS | Buy | FIGURE ACQUISITION CORP I*w exp 03/31/202 | $16,000 | -44.8% | 24,999 | +0.0% | 0.00% | -50.0% |
| DHHCW | DIAMONDHEAD HOLDINGS CORP*w exp 01/28/202 | $8,000 | -46.7% | 24,999 | 0.0% | 0.00% | 0.0% | |
| HIIIW | HUDSON EXECUTIVE INVES III*w exp 02/22/202 | $8,000 | -50.0% | 19,999 | 0.0% | 0.00% | 0.0% | |
| COLIW | COLICITY INC*w exp 02/24/202 | $8,000 | -46.7% | 19,999 | 0.0% | 0.00% | 0.0% | |
| EQHAWS | EQ HEALTH ACQUISITION CORP*w exp 02/02/202 | $9,000 | -30.8% | 24,999 | 0.0% | 0.00% | 0.0% | |
| SHACW | SCP & CO HEALTHCARE ACQUSTN*w exp 01/27/202 | $8,000 | -71.4% | 50,000 | 0.0% | 0.00% | -50.0% | |
| VIIAW | 7GC & CO HOLDINGS INC*w exp 12/23/202 | $19,000 | -66.1% | 92,499 | 0.0% | 0.00% | -66.7% | |
| BIOTW | BIOTECH ACQUISITION COMPANY*w exp 11/30/202 | $12,000 | -63.6% | 50,000 | 0.0% | 0.00% | -50.0% | |
| CPTKWS | CROWN PROPTECH ACQUISITIONS*w exp 99/99/999 | $9,000 | -52.6% | 33,333 | 0.0% | 0.00% | 0.0% | |
| DLCAW | DEEP LAKE CAPITAL ACQUSTN CO*w exp 01/04/202 | $12,000 | -67.6% | 60,000 | 0.0% | 0.00% | -50.0% | |
| AACWS | ARES ACQUISITION CORPORATION*w exp 99/99/999 | $8,000 | -55.6% | 20,000 | 0.0% | 0.00% | 0.0% | |
| FCAXWS | FORTRESS CAPITAL ACQUISITION*w exp 99/99/999 | $12,000 | -47.8% | 29,999 | 0.0% | 0.00% | 0.0% | |
| IIIIW | INSU ACQUISITION CORP III*w exp 12/31/202 | $7,000 | -65.0% | 33,333 | 0.0% | 0.00% | -100.0% | |
| HCCCW | Exit | HEALTHCARE CAPITAL CORP*w exp 12/31/202 | $0 | – | -50,000 | -100.0% | -0.00% | – |
| SPAQWS | Exit | SPARTAN ACQUISITION CORP III*w exp 02/04/202 | $0 | – | -37,499 | -100.0% | -0.00% | – |
| NXUWS | Exit | NOVUS CAPITAL CORPORATION II*w exp 02/02/202 | $0 | – | -49,999 | -100.0% | -0.00% | – |
| PAQC | Exit | PROVIDENT ACQUISITION CORPcl a | $0 | – | -37,731 | -100.0% | -0.02% | – |
| FACA | Exit | FIGURE ACQUISITION CORP I | $0 | – | -50,000 | -100.0% | -0.03% | – |
| EQHA | Exit | EQ HEALTH ACQUISITION CORP | $0 | – | -50,000 | -100.0% | -0.03% | – |
| AAC | Exit | ARES ACQUISITION CORPORATION | $0 | – | -50,000 | -100.0% | -0.03% | – |
| BIOT | Exit | BIOTECH ACQUISITION COMPANY | $0 | – | -93,250 | -100.0% | -0.05% | – |
| HIII | Exit | HUDSON EXECUTIVE INVES III | $0 | – | -100,000 | -100.0% | -0.06% | – |
| SHAC | Exit | SCP & CO HEALTHCARE ACQUSTN | $0 | – | -100,000 | -100.0% | -0.06% | – |
| CPTK | Exit | CROWN PROPTECH ACQUISITIONS | $0 | – | -100,000 | -100.0% | -0.06% | – |
| Exit | RXR ACQUISITION CORP | $0 | – | -100,000 | -100.0% | -0.06% | – | |
| DHHC | Exit | DIAMONDHEAD HOLDINGS CORPcl a | $0 | – | -100,000 | -100.0% | -0.06% | – |
| COLI | Exit | COLICITY INC | $0 | – | -100,000 | -100.0% | -0.06% | – |
| CFIV | Exit | CF ACQUISITION CORP IV | $0 | – | -163,000 | -100.0% | -0.09% | – |
| CFVI | Exit | CF ACQUISITION CORP VI | $0 | – | -150,000 | -100.0% | -0.09% | – |
| PRPC | Exit | CC NEUBERGER PRINCIPAL HOLDN | $0 | – | -400,000 | -100.0% | -0.22% | – |
| BGSX | Exit | BUILD ACQUISITION CORP | $0 | – | -450,000 | -100.0% | -0.25% | – |
| Exit | HEALTHCARE AI ACQUISITION COunit 12/07/2026 | $0 | – | -480,433 | -100.0% | -0.27% | – | |
| LCA | Exit | LANDCADIA HOLDINGS IV INC | $0 | – | -500,000 | -100.0% | -0.28% | – |
| AFAQ | Exit | AF ACQUISITION CORP | $0 | – | -600,000 | -100.0% | -0.33% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -2,222,931 | -100.0% | -10.36% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Centerbridge Credit Advisors, L.L.C. #1
- Centerbridge Partners Holdings, LLC #2
- Aronson Jeffrey #3
- Centerbridge Special Credit Advisors, L.L.C. #4
- Centerbridge Advisors, LLC #5
- Centerbridge Special Credit Advisors II, L.L.C #6
- Centerbridge Special Credit Advisors III, L.L.C. #7
- Centerbridge Advisors II, LLC #8
- Centerbridge Advisors III, LLC #9
- Centerbridge Partners Real Estate Advisors, LLC #10
- Centerbridge Partners Real Estate Advisors II, LLC #11
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
About Centerbridge Partners
Centerbridge Partners is a private investment management firm that was founded in 2005 by Mark Gallogly and Jeffrey Aronson. The firm is headquartered in New York City and has additional offices in London and Hong Kong. Centerbridge Partners manages over $25 billion in assets across a range of investment strategies, including private equity, distressed debt, and real estate.
The firm has a strong leadership team, with Mark Gallogly serving as the CEO and Jeffrey Aronson as the Chairman and Chief Investment Officer. The COO is William Rahm, who oversees the firm's operations and infrastructure.
Centerbridge Partners has a reputation for being a highly disciplined and opportunistic investor, with a focus on identifying undervalued assets and unlocking value through operational improvements. The firm has a track record of successfully investing in a range of industries, including healthcare, energy, and financial services.
One notable investment made by Centerbridge Partners was its acquisition of Syncora Holdings, a financial guarantee insurance company, in 2013. The firm was able to turn around the struggling company by implementing operational improvements and strategic initiatives, ultimately leading to a successful exit.
Overall, Centerbridge Partners is a well-respected investment management firm with a strong leadership team and a proven track record of success.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GENCO SHIPPING & TRADING LTD | 26 | Q4 2022 | 18.0% |
| AMERICAN RENAL ASSOCS HLDGS | 19 | Q4 2020 | 34.8% |
| EXTENDED STAY AMER INC | 18 | Q4 2020 | 64.1% |
| AMBAC FINL GROUP INC | 17 | Q1 2018 | 4.8% |
| QUAD / GRAPHICS INC | 16 | Q4 2017 | 6.1% |
| IRSA INVERSIONES Y REP S A | 16 | Q3 2019 | 1.4% |
| ALLY FINL INC | 15 | Q4 2017 | 12.4% |
| WMIH CORP | 13 | Q3 2018 | 2.5% |
| CRESUD S A C I F Y A | 13 | Q4 2016 | 0.8% |
| ATLANTICA YIELD PLC | 12 | Q1 2019 | 9.0% |
View Centerbridge Partners's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| KV PHARMACEUTICAL CO /DE/ | March 03, 2011 | ? | ? |
View Centerbridge Partners's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 40-APP/A | 2024-03-04 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 40-APP | 2023-10-16 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Centerbridge Partners's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.